December 13, 2018
A Maryland federal judge has tossed claims brought by regenerative medicine company Osiris Therapeutics Inc. that its rival MiMedx Group Inc. breached a contract and stole trade secrets when the company acquired Osiris' former distributor, holding that the court lacked jurisdiction to hear the lawsuit.
April 03, 2018
Regenerative medicine company MiMedx Group Inc. used its acquisition of a distributor to steal clients and withhold commissions from rival Osiris Therapeutics Inc., according to a $6.8 million suit filed in Maryland federal court Monday.